Ikarian Capital, LLC Adma Biologics, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.8 - $2.56 $360,000 - $512,000	-200,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.04 - $3.74 $364,290 - $667,866	-178,574 Reduced 47.17%	200,000 $478,000
Q2 2020 Aug 14, 2020	SELL	$2.42 - $3.29 $608,450 - $827,191	-251,426 Reduced 39.91%	378,574 $1.11 Million
Q1 2020 May 15, 2020	BUY	$1.5 - $4.59 $945,000 - $2.89 Million	630,000 New	630,000 $1.81 Million

317

185M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.74B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.